Global Fumonisin B1 Market Growth 2023-2029

Global Fumonisin B1 Market Growth 2023-2029

Fumonisin B1 is a mycotoxin produced by Fusarium moniliforme that has been shown to potently inhibit sphingosine N-acyltransferase, thereby disrupting the synthesis of sphingolipids, a key component of plasma membranes.

LPI (LP Information)' newest research report, the “Fumonisin B1 Industry Forecast” looks at past sales and reviews total world Fumonisin B1 sales in 2022, providing a comprehensive analysis by region and market sector of projected Fumonisin B1 sales for 2023 through 2029. With Fumonisin B1 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fumonisin B1 industry.

This Insight Report provides a comprehensive analysis of the global Fumonisin B1 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fumonisin B1 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Fumonisin B1 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fumonisin B1 and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fumonisin B1.

The global Fumonisin B1 market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Fumonisin B1 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Fumonisin B1 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Fumonisin B1 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Fumonisin B1 players cover Adooq Bioscience, LKT Laboratories, Abcam, Spectrum Chemical, StressMarq Biosciences, Biosynth Carbosynth, LGC, Cayman Chemical and Santa Cruz Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Fumonisin B1 market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segmentation by application
Research
Medical

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adooq Bioscience
LKT Laboratories
Abcam
Spectrum Chemical
StressMarq Biosciences
Biosynth Carbosynth
LGC
Cayman Chemical
Santa Cruz Biotechnology
Bio-Techne
Merck
Enzo Biochem
Focus Biomolecules
STEMCELL Technologies
APExBIO Technology
Pharmaffiliates
Cato Research Chemicals
Aladdin

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fumonisin B1 market?

What factors are driving Fumonisin B1 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fumonisin B1 market opportunities vary by end market size?

How does Fumonisin B1 break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.